Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2005 | 12-2004 | 09-2004 | 06-2004 | 03-2004 | |
| Sales | 400,828 | 423,507 | 408,018 | 399,368 | 409,658 |
| Cost of Goods | 206,950 | 222,951 | 202,508 | 198,854 | 196,481 |
| Gross Profit | 193,878 | 200,556 | 205,510 | 200,514 | 213,177 |
| Operating Expenses | 134,077 | 111,084 | 179,487 | 140,535 | 125,505 |
| Operating Income | 60,751 | 90,423 | 26,531 | 60,833 | 88,153 |
| Interest Expense | 3,290 | 4,259 | 3,681 | 1,647 | 3,743 |
| Other Income | 4,004 | -971 | 26 | -4,607 | -11,495 |
| Pre-tax Income | 61,465 | 85,193 | 22,876 | 54,579 | 72,915 |
| Income Tax | 22,852 | 31,402 | 8,235 | 19,652 | 26,256 |
| Net Income Continuous | 38,613 | 53,791 | 14,641 | 34,927 | 46,659 |
| Net Income | $38,613 | $53,791 | $14,641 | $34,927 | $46,659 |
| EPS Basic Total Ops | 0.35 | 0.49 | 0.13 | 0.32 | 0.43 |
| EPS Basic Continuous Ops | 0.35 | 0.49 | 0.13 | 0.32 | 0.43 |
| EPS Diluted Total Ops | 0.32 | 0.45 | 0.13 | 0.29 | 0.39 |
| EPS Diluted Continuous Ops | 0.31 | 0.43 | 0.12 | 0.28 | 0.37 |
| EBITDA(a) | $110,754 | $118,777 | $53,853 | $86,865 | $113,111 |